Ms. Dodd has over 23 years of experience in the development and conduct of health economics, outcomes research, clinical research, reimbursement and policy activities across the pharmaceutical, medical device and international public health sectors.
In June 2015, Sheri was appointed as the Vice President and General Manager for the Patient Management Services business at Medtronic, LLC. In addition to leading Cardiocom, a patient monitoring service that Medtronic acquired in 2013, Sheri will be responsible for building out the broader patient management services business, platform and associated business models. Sheri joined Medtronic in March 2010 as Vice President for Reimbursement, Economics and Health Policy for the Cardiac Rhythm & Heart Failure (CRHF) business. Her responsibilities expanded to lead the CRHF Global Clinical Research function. In July 2014, she was promoted to Vice President, Global Health Economics and Market Access for Cardiac and Vascular Group(CVG).
Prior to joining Medtronic, Sheri spent 13 years at Johnson & Johnson in a variety of regional and global positions in both the Pharmaceutical and Medical Device sector. Prior to joining Industry, Sheri spent 5 years at the World Health Organization in Geneva, Switzerland, with responsibility for the implementation of disease management and health policy interventions for 22 countries in the Arab Middle Eastern region. After returning to the US she worked in an office-based clinical practice, leading the implementing clinical office-based outcomes research studies in the area of orthopedics, internal medicine and obstetrics and gynecology.
Sheri earned a joint Master’s of Science degree from the London School of Economics and the London School of Hygiene and Tropical Medicine and has completed several certificate programs from the University of York and Harvard School of Public Health.